Advertisement
Australia markets closed
  • ALL ORDS

    8,118.30
    -1.90 (-0.02%)
     
  • AUD/USD

    0.6648
    -0.0022 (-0.33%)
     
  • ASX 200

    7,848.10
    -3.60 (-0.05%)
     
  • OIL

    77.91
    -0.75 (-0.95%)
     
  • GOLD

    2,415.50
    -10.40 (-0.43%)
     
  • Bitcoin AUD

    104,679.06
    -2,588.99 (-2.41%)
     
  • CMC Crypto 200

    1,511.25
    -15.17 (-0.99%)
     

Better Buy: AbbVie vs. Johnson & Johnson

Better Buy: AbbVie vs. Johnson & Johnson

AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.